Tea Zeppola

1.3k total citations
6 papers, 134 citations indexed

About

Tea Zeppola is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tea Zeppola has authored 6 papers receiving a total of 134 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 2 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tea Zeppola's work include Pancreatic and Hepatic Oncology Research (3 papers), Cancer Genomics and Diagnostics (2 papers) and Pain Management and Opioid Use (1 paper). Tea Zeppola is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Cancer Genomics and Diagnostics (2 papers) and Pain Management and Opioid Use (1 paper). Tea Zeppola collaborates with scholars based in Italy. Tea Zeppola's co-authors include Daniele Santini, Giuseppe Tonini, Emanuela Dell’Aquila, Bruno Vincenzi, Fabrizio Citarella, Francesco Pantano, Marco Russano, Alessandro Minelli, Maria Concetta Cursano and Claudia Angela Maria Fulgenzi and has published in prestigious journals such as Journal of Clinical Oncology, Oncotarget and Critical Reviews in Oncology/Hematology.

In The Last Decade

Tea Zeppola

6 papers receiving 133 citations

Peers

Tea Zeppola

ONCOL

PRM

CR

MB

SURGE

Moyan Zhang China

Rosa Rita Silva Italy

Nieves Martínez Lago Spain

Ryotaro Ohkuma Japan

Wenhui Wu China

Juan Martínez Spain

Arun Nagarajan United States

Ilaria Depetris Italy

Mathieu Baconnier France

Tetsuji Terazawa Japan

Moyan Zhang China

Tea Zeppola

80 ×0.8

ONCOL

71 ×1.4

PRM

44 ×0.9

CR

63 ×1.8

MB

25 ×1.4

SURGE

Citations per year, relative to Tea Zeppola Tea Zeppola (= 1×) peers Moyan Zhang

Countries citing papers authored by Tea Zeppola

Since Specialization

Citations

This map shows the geographic impact of Tea Zeppola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tea Zeppola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tea Zeppola more than expected).

Fields of papers citing papers by Tea Zeppola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tea Zeppola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tea Zeppola. The network helps show where Tea Zeppola may publish in the future.

Co-authorship network of co-authors of Tea Zeppola

This figure shows the co-authorship network connecting the top 25 collaborators of Tea Zeppola. A scholar is included among the top collaborators of Tea Zeppola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tea Zeppola. Tea Zeppola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Dell’Aquila, Emanuela, Grazia Armento, Michele Iuliani, et al.. (2020). Denosumab for cancer-related bone loss. Expert Opinion on Biological Therapy. 20(11). 1261–1274. 17 indexed citations

2.

Dell’Aquila, Emanuela, Tea Zeppola, Marco Stellato, et al.. (2020). Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?. Clinical Medicine Insights Oncology. 14. 2282642437–2282642437. 7 indexed citations

3.

Pantano, Francesco, Paolo Manca, Grazia Armento, et al.. (2020). Breakthrough cancer pain clinical features and differential opioids response: A machine learning approach in 4,016 cancer patients of IOPS-MS study.. Journal of Clinical Oncology. 38(15_suppl). e24150–e24150. 1 indexed citations

4.

Dell’Aquila, Emanuela, Claudia Angela Maria Fulgenzi, Alessandro Minelli, et al.. (2020). Prognostic and predictive factors in pancreatic cancer. Oncotarget. 11(10). 924–941. 61 indexed citations

5.

Aprile, Giuseppe, Francesca Negri, Francesco Giuliani, et al.. (2017). Second-line chemotherapy for advanced pancreatic cancer: Which is the best option?. Critical Reviews in Oncology/Hematology. 115. 1–12. 23 indexed citations

6.

Santoni, Matteo, Alessandro Conti, Luciano Burattini, et al.. (2014). Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma. Critical Reviews in Oncology/Hematology. 92(3). 208–217. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact